Omar Khan
Director of Cell Therapy

Omar Khan most recently served as the Director of Molecular Immunology at ArsenalBio, an engineered cell therapy start-up. At Arsenal, he led the efforts to discover key gene targets that augment immune cell behavior as well as the development of a novel platform to augment cell transcriptional signatures for cell therapy products. Obtained my Ph.D. from the University of Pennsylvania in Immunology, where he studied the transcriptional and epigenetic factors that regulate T cell differentiation and T cell exhaustion in the setting of chronic viral infection and cancer.